Related references
Note: Only part of the references are listed.Genomic responses in mouse models poorly mimic human inflammatory diseases
Junhee Seok et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
The B-cell receptor signaling pathway as a therapeutic target in CLL
Jennifer A. Woyach et al.
BLOOD (2012)
Randomized, double-blind, placebo-controlled trial of sulindac in individuals at risk for melanoma
Clara Curiel-Lewandrowski et al.
CANCER (2012)
Widespread potential for growth-factor-driven resistance to anticancer kinase inhibitors
Timothy R. Wilson et al.
NATURE (2012)
Bortezomib Combination Therapy in Multiple Myeloma
Prashant Kapoor et al.
SEMINARS IN HEMATOLOGY (2012)
Cisplatin and a potent platinum(IV) complex-mediated enhancement of TRAIL-induced cancer cells killing is associated with modulation of upstream events in the extrinsic apoptotic pathway
Olga Vondalova Blanarova et al.
CARCINOGENESIS (2011)
Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
Paul B. Chapman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Caspase-3 cleaves XIAP in a positive feedback loop to sensitize melanoma cells to TRAIL-induced apoptosis
M. Hoernle et al.
ONCOGENE (2011)
A Temporarily Distinct Subpopulation of Slow-Cycling Melanoma Cells Is Required for Continuous Tumor Growth
Alexander Roesch et al.
CELL (2010)
Treatment for metastatic malignant melanoma: Old drugs and new strategies
Roger Mouawad et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2010)
Multicellular tumor spheroids: An underestimated tool is catching up again
Franziska Hirschhaeuser et al.
JOURNAL OF BIOTECHNOLOGY (2010)
Isolation and cultivation of human keratinocytes from skin or plucked hair for the generation of induced pluripotent stem cells
Trond Aasen et al.
NATURE PROTOCOLS (2010)
Inhibition of Mutated, Activated BRAF in Metastatic Melanoma
Keith T. Flaherty et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Smac mimetics as new cancer therapeutics
Derrick J. Chen et al.
ANTI-CANCER DRUGS (2009)
Basement membranes in skin: unique matrix structures with diverse functions?
Dirk Breitkreutz et al.
HISTOCHEMISTRY AND CELL BIOLOGY (2009)
Final Version of 2009 AJCC Melanoma Staging and Classification
Charles M. Balch et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Sensitization of melanoma cells to TRAIL by UVB-induced and NF-κB-mediated downregulation of xIAP
B. Thayaparasingham et al.
ONCOGENE (2009)
Recent advances in three-dimensional multicellular spheroid culture for biomedical research
Ruei-Zhen Lin et al.
Biotechnology Journal (2008)
Melanoma stem cells: The dark seed of melanoma
Susan E. Zabierowski et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
RBP2-H1/JARID1B is a transcriptional regulator with a tumor suppressive potential in melanoma cells
Alexander Roesch et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Human agonistic TRAIL receptor antibodies Mapatumumab and Lexatumumab induce apoptosis in malignant mesothelioma and act synergistically with cisplatin
Larisa L. Belyanskaya et al.
MOLECULAR CANCER (2007)
Combined targeting of MAPK and AKT signalling pathways is a promising strategy for melanoma treatment
F. Meier et al.
BRITISH JOURNAL OF DERMATOLOGY (2007)
Differential effects of NF-κB on apoptosis induced by DNA-damaging agents:: the type of DNA damage determines the final outcome
E. Strozyk et al.
ONCOGENE (2006)
Preclinical differentiation between apparently safe and potentially hepatotoxic applications of TRAIL either alone or in combination with chemotherapeutic drugs
TM Ganten et al.
CLINICAL CANCER RESEARCH (2006)
The Ras/Raf/MEK/ERK and PI3K/AKT signaling pathways present molecular targets for the effective treatment of advanced melanoma
F Meier et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2005)
ABCB5-mediated doxorubicin transport and chemoresistance in human malignant melanoma
NY Frank et al.
CANCER RESEARCH (2005)
Prognostic significance of activated Akt expression in melanoma: A clinicopathologic study of 292 cases
DL Dai et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Palliative therapy of disseminated malignant melanoma: a systematic review of 41 randomised clinical trials
TK Eigentler et al.
LANCET ONCOLOGY (2003)
Regulation of progenitor cell fusion by ABCB5 P-glycoprotein, a novel human ATP-binding cassette transporter
NY Frank et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
20 years after - Milestones in molecular photobiology
D Kulms et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY SYMPOSIUM PROCEEDINGS (2002)
Human melanoma progression in skin reconstructs - Biological significance of bFGF
F Meier et al.
AMERICAN JOURNAL OF PATHOLOGY (2000)
Share Paper
